When did Cytek Biosciences, Inc. report Q4 2024 earnings?

Cytek Biosciences, Inc. (CTKB) reported Q4 2024 earnings on February 27, 2025 after market close.

What were Cytek Biosciences, Inc.'s Q4 2024 revenue and EPS?

Cytek Biosciences, Inc. reported revenue of $57.5M and eps of $0.07 for Q4 2024.

Did Cytek Biosciences, Inc. beat estimates in Q4 2024?

Revenue missed the consensus estimate of $59.4M by $1.9M. EPS beat the consensus estimate of $0.05 by $0.02.

Where can I find Cytek Biosciences, Inc.'s Q4 2024 SEC filings?

You can read the 10-K periodic report (0001628280-25-008780) directly on SEC EDGAR. The filing index links above go to sec.gov.

Cytek Biosciences, Inc. CTKB Q4 2024 Annual earnings

Reported February 27, 2025 · After market close

Revenue$57.5MMiss by $1.9M

EPS$0.07Beat by $0.02

Revenue estimate$59.4M

EPS estimate$0.05

Next report

Aug 5, 2026 (In 1 week)

Revenue estimate$47.3M

EPS estimate-$0.02

Financials

Q4 2024

Income statement

See full

Revenue$57.5M-1.3%

Gross profit$33.7M+1.8%

Balance sheet

See full

Cash & equivalents$98.7M-41.0%

Total debt$12.4M-8.9%

Total equity$395.7M+0.7%

Total assets$499.5M+1.0%

Cash flow

See full

Operating cash flow$2.0M-79.0%

CapEx$894.0K-40.4%

Free cash flow$1.1M-86.2%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$835.98M-29.9%

Enterprise value$749.59M-27.8%

P/S4.2×-2.0×

Profitability

See full

Gross margin55.4%-1.3pp

FCF margin10.9%+10.6pp

Returns & leverage

See full

Debt / equity0×0.0×

Current ratio5.9×-1.1×

Segments

By geography

See full

EMEA$16.2M-17.8%

APAC$11.5M+20.7%

Other$5.3M+183%

By segment

See full

Reportable Segment$57.5M+19.1%

By product

See full

Service$12.5M+7.5%

Versus estimates

Revenue

Q1 2026$44.1MMiss by $98.3K Q4 2025$62.1MBeat by $5.0M Q3 2025$52.3MMiss by $6.5M Q2 2025$45.6MMiss by $747.0K Q1 2025$41.5MMiss by $1.2M

Q4 2024$57.5MMiss by $1.9M

Diluted EPS

Q1 2026-$0.12Miss by $0.04 Q4 2025-$0.01Beat by $0.01 Q3 2025-$0.01Miss by $0.02 Q2 2025$0.01Beat by $0.03 Q1 2025-$0.09Miss by $0.05

Q4 2024$0.07Beat by $0.02

Ask the moment Cytek Biosciences, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Cytek Biosciences, Inc. report Q4 2024 earnings?: Cytek Biosciences, Inc. (CTKB) reported Q4 2024 earnings on February 27, 2025 after market close.
What were Cytek Biosciences, Inc.'s Q4 2024 revenue and EPS?: Cytek Biosciences, Inc. reported revenue of $57.5M and eps of $0.07 for Q4 2024.
Did Cytek Biosciences, Inc. beat estimates in Q4 2024?: Revenue missed the consensus estimate of $59.4M by $1.9M. EPS beat the consensus estimate of $0.05 by $0.02.
Where can I find Cytek Biosciences, Inc.'s Q4 2024 SEC filings?: You can read the 10-K periodic report (0001628280-25-008780) directly on SEC EDGAR. The filing index links above go to sec.gov.